Reactive oxygen species as glomerular autacoids.
There is considerable evidence suggesting that reactive oxygen species (ROS; superoxide anion, hydrogen peroxide, hydroxyl radical, hypochlorous acid) are implicated in the pathogenesis of toxic, ischemic, and immunologically mediated glomerular injury. The capacity of glomerular cells, especially mesangial cells, to generate ROS in response to several stimuli suggests that these autacoids may play a role in models of glomerular injury that are independent of infiltrating polymorphonuclear leukocytes and monocytes. The mechanisms whereby ROS formation results in morphologic lesions and in modifications of glomerular permeability, blood flow, and filtration rate have been inferred from in vitro studies. They involve direct and indirect injury to resident cells (mesangiolysis) and glomerular basement membrane (in concert with metalloproteases) and alteration of both the release and binding of vasoactive substances, such as bioactive lipids (e.g., prostaglandin E2, prostacyclin, thromboxane), cytokines (e.g., tumor necrosis factor alpha), and possibly endothelium-derived relaxing factor. The importance of such processes appears to be modulated by the intrinsic antioxidant defenses of the glomeruli. Further studies are needed to address the role of ROS in human glomerular diseases.
Baud
L
L
INSERM U. 64, Hôpital Tenon, Paris, France.
Fouqueray
B
B
Philippe
C
C
Ardaillou
R
R
D000818:Animals; D015777:Eicosanoids / Q000096:biosynthesis; D005609:Free Radicals; D005920:Glomerular Mesangium / Q000378:metabolism; D006801:Humans; D007678:Kidney Glomerulus / Q000293:injuries / Q000378:metabolism*; D009569:Nitric Oxide / Q000378:metabolism; D010100:Oxygen / Q000378:metabolism*; D010972:Platelet Activating Factor / Q000096:biosynthesis; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis
D015777:Eicosanoids; D005609:Free Radicals; D010972:Platelet Activating Factor; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D010100:Oxygen